Breast CAncer

Health Outcomes Following In Utero Exposure to Maternal Cancer

By

Vicki Moore, PhD

Publish Date August 2, 2022

Researchers in Denmark sought to determine whether in utero exposure to maternal cancer increased risks of overall mortality, somatic diagnoses, and psychiatric diagnoses.

Pembrolizumab Improves OS in Triple-Negative Breast Cancer With High PD-L1 Expression

By

Leah Lawrence

Publish Date July 29, 2022

Patients with a PD-L1 combined positive score of 10 or higher had a significant improvement in overall survival with pembrolizumab.

Medically Integrated Dispensing on the Rise in US Oncology Practices

By

Leah Lawrence

Publish Date July 28, 2022

From 2010 to 2019, the percentage of oncology practices with medically integrated dispensing more than doubled.

Enhertu Gets Priority Review for HER2-Low Metastatic Breast Cancer

By

Brian Park, PharmD

Publish Date July 27, 2022

The sBLA is supported by data from the phase 3 DESTINY-Breast04 trials.

Delay to Biopsy After Mammography Varies by Ethnicity in US

By

Jessica Nye, PhD

Publish Date July 26, 2022

A study evaluated the time to biopsy following abnormal screening mammography results for women by ethnicity.

Pertuzumab Provides Long-Term Benefit in HER2+, Operable Breast Cancer

By

Andrea S. Blevins Primeau, PhD, MBA

Publish Date July 25, 2022

Adding pertuzumab to adjuvant chemotherapy and trastuzumab can improve long-term outcomes in operable, HER2+ early breast cancer, data suggest.

Effects of Breast Cancer Treatments on Cardiovascular Disease Risk Factors

By

Julie Scott, ANP-BC, AOCNP

Publish Date July 21, 2022

A review of the results of the Pathways Heart Study, which sought to identify the link between a history of breast cancer treatment and cardiovascular risks in women.

Childbirth Linked to Increased Risk of Triple-Negative Breast Cancer

By

Andrea S. Blevins Primeau, PhD, MBA

Publish Date July 18, 2022

Childbirth is associated with an increased risk of triple-negative breast cancer that persist over time, a large study suggests.

Diagnostic Mammogram Performance Varies by Race/Ethnicity

Publish Date July 14, 2022

Invasive cancer detection rates, positive predictive values highest for non-Hispanic Whites, lowest for Hispanics.

Epigallocatechin-3-Gallate Prophylaxis Reduced Incidence, Severity of Radiation-Induced Dermatitis in Breast Cancer

By

Vicki Moore, PhD

Publish Date July 12, 2022

Researchers sought to determine the efficacy of epigallocatechin-3-gallate prophylaxis in reducing incidence and severity of radiation-induced dermatitis in patients with breast cancer undergoing postoperative radiotherapy.